55CLINICAL STUDIES PEDIATRIC STUDIES
Conclusions Traumeel® proved effective in all pediatric age groups (infants, pre-schoolers and
school-age children) and for all of the usage indications reported. Traumeel® is reliably effective in treating both blunt trauma and muscle, joint and
soft-tissue disorders of varying etiology in pediatric patients.
Results Overall analysis of the therapeutic results indicated that the treatment was rated
(regardless of age or type of symptoms) as very good in 70% of patients and good in 27% of patients (Figure 23).
Monotherapy with Traumeel® was rated as very good or good in 98% of patients.
Symptoms improved within 1 day of application in 7% of patients, and within 1 3 days in two thirds of the patients. A further 24% saw improvement by the end of the first week of treatment.
Pe rc
en ta
ge o
f p at
ie nt
s
Very good Good Satisfactory No improvement
100
90
80
70
60
50
40
30
20
10
0 A B Fc D E
A = total patient population (n=157) B = contusions (n=50) C = sprains (n=37)
D = hematomas (n=26) E = dislocations (n=11) F = Traumeel® monotherapy (n=97)
Figure 23 Results of therapy with Traumeel®.
